Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Neuraxis Stock Price, Quotes and Forecasts | AMEX:NRXS | Benzinga

Q: What sector and industry does Neuraxis (NRXS) operate in?

Neuraxis is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the AMEX.

Explore Neuraxis stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NRXS.

Open	$2.04
Close	$2.13
Volume / Avg.	2.06K / 23.20K
Day Range	$2.04 - $2.18
52 Wk Range	1.99 - 3.78
Market Cap	$15.38M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	43
Short Interest	0.62%
Days to Cover	1.23

Recent News

Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock.

Lisa Levin

EXCLUSIVE: NeurAxis' Nerve Field Stimulation Tech Shows Improved Quality of Life of Adolescents Patients With Irritable Bowel Syndrome

NeurAxis Inc (NYSE: NRXS) announced the publication of a Prospective study evaluating the efficacy of IB-Stim in children featured in the September 2023 Frontiers in Pain Research.

Vandana Singh

EXCLUSIVE: Small MedTech Firm NeurAxis Targets $2B Market With Post-Concussion Therapy In Kids

NeurAxis Inc (NYSE: NRXS) highlighted A Prospective Study on the Effect of Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients with Post-Concussion Syndrome (PCS), a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of IB-Stim in children with post-conc

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$2.04
Close	$2.13
Volume / Avg.	2.06K / 23.20K
Day Range	$2.04 - $2.18
52 Wk Range	1.99 - 3.78
Market Cap	$15.38M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	43
Short Interest	0.62%
Days to Cover	1.23

About Neuraxis Inc

Sector

Health Care

Industry

Health Care Equipment & Supplies

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Neuraxis (NRXS) stock?

You can purchase shares of Neuraxis (AMEX:NRXS) through any online brokerage.

View our list of the best stock brokerages

Who are Neuraxis (NRXS) competitors?

Other companies in Neuraxis’s space includes: Precision Optics Corp (NASDAQ:POCI), Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL), Modular Medical (NASDAQ:MODD) and NeuroOne Medical Tech (NASDAQ:NMTC).

What is the forecast, or price target, for Neuraxis (NRXS) stock?

There is no analysis for Neuraxis to provide a consensus price target.

What is the current price for Neuraxis (NRXS)?

The stock price for Neuraxis (AMEX: NRXS) is $2.1313 last updated March 27, 2025 at 8:00 PM EDT.

Does Neuraxis (NRXS) pay a dividend?

There are no upcoming dividends for Neuraxis.

When is Neuraxis (AMEX:NRXS) reporting earnings?

Neuraxis’s Q1 earnings are confirmed for Wednesday, May 21, 2025.

Is Neuraxis (NRXS) going to split?

There is no upcoming split for Neuraxis.

What sector and industry does Neuraxis (NRXS) operate in?

Neuraxis is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the AMEX.

Comments

Neuraxis Stock Price, Quotes and Forecasts

Neuraxis (NRXS) Forecast